세계의 정맥주사액 시장 보고서(2025년)

Intravenous Solutions Global Market Report 2025

US $ 4,490 ￦ 6,371,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,209,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,048,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

정맥주사액 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 8.0%의 성장률(CAGR)로 205억 1,000만 달러에 달할 것으로 예측됩니다. 예측 기간의 성장은 인구 증가와 고령화, 외과 수술 증가, 감염성 질환 이환율 증가, 원격 의료 및 원격 환자 모니터링, 예방적 건강 관리의 중요성, 세계 의료 안보 투자, 환자 중심 케어 트렌드 등에 기인합니다. 예측 기간의 주요 동향으로는 비경구 영양제 수요 증가, 프리믹스 수액 채택 증가, 재택 수액 요법 확대, 전해질 균형 수액 도입, 신규 약물 첨가제 및 보조제 도입, 모니터링용 스마트 수액 시스템 통합 등을 꼽을 수 있습니다.

암 유병률 증가는 향후 몇 년 동안 정맥주사액 시장의 성장을 견인할 것으로 예상됩니다. 암은 통제할 수 없는 세포 증식을 특징으로 하며, 주변 조직으로 침윤하거나 신체의 다른 부위로 전이될 수 있는 다양한 질병을 포괄합니다. 정맥 주사는 항암제 투여 및 치료 중 환자의 수분 공급을 유지하기 위해 암 치료에 자주 활용되고 있습니다. 예를 들어, 2024년 2월 스위스에 본부를 둔 정부 간 기구인 세계보건기구(WHO)는 2050년까지 새로 발생하는 암 환자가 3,500만 명을 넘어 2022년에 보고된 약 2,000만 명보다 77% 증가할 것으로 예측했습니다. 결과적으로 암 발병률 증가는 정맥주사액 시장의 성장을 견인하고 있습니다.

또한, 외과 수술 증가는 정맥주사액 시장 확대에 기여할 것으로 예상됩니다. 절개 및 침습적 접근 방식으로 다양한 질병 및 장애를 치료하는 수술은 수분 보충, 전해질 균형, 약물 관리, 응급 개입 등 필수적인 지원을 위해 정맥 주사액에 의존하고 있습니다. 일례로 2023년 9월 국제미용성형외과학회가 발표한 데이터에 따르면 2022년 전 세계 성형외과 의사가 시행한 수술 건수는 약 1,490만 건, 비수술 건수는 1,880만 건으로 총 수술 건수는 11.2% 증가하였습니다. 따라서 수술 건수 증가가 정맥주사액 시장의 성장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 정맥주사액 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업 분석
• 세계의 정맥주사액 시장 : 성장률 분석
• 세계의 정맥주사액 시장 실적 : 규모와 성장, 2019-2024
• 세계의 정맥주사액 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 정맥주사액 전체 시장(TAM)

제6장 시장 세분화

• 세계의 정맥주사액 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 완전 정맥 영양
• 말초 정맥 영양
• 세계의 정맥주사액 시장 : 영양소별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 탄수화물
• 비타민 및 미네랄
• 아미노산 단회 투여
• 비경구 지질 유제
• 기타 영양소
• 세계의 정맥주사액 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 기본적인 정맥내(IV) 용액
• 영양 점적(IV) 용액
• 혈액 정맥내(IV) 용액
• 약제 정맥내(IV) 용액
• 세정 정맥내(IV) 용액
• 세계의 정맥주사액 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 클리닉
• 외래수술센터(ASC)
• 가정치료 환경
• 세계의 정맥주사액 시장 : 완전 정맥 영양(TPN) 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 탄수화물 솔루션
• 아미노산 솔루션
• 지질 솔루션
• 전해질 용액
• 멀티 비타민 솔루션
• 세계의 정맥주사액 시장 : 말초 정맥 영양(PPN)별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 탄수화물 솔루션
• 아미노산 솔루션
• 지질 솔루션
• 전해질 용액

제7장 지역별/국가별 분석

• 세계의 정맥주사액 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 정맥주사액 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 정맥주사액 시장 : 경쟁 구도
• 정맥주사액 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Baxter International Inc.
• Otsuka Pharmaceutical Co. Ltd.
• CSL Limited
• B. Braun Melsungen AG
• Grifols S.A.
• Terumo Corporation
• Nipro Corporation
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Cipla Limited
• Hikma Pharmaceuticals PLC
• ICU Medical Inc.
• Gland Pharma Limited
• Cisen Pharmaceutical Co. Ltd.
• Amsino International Inc.
• JW Life Science Co. Ltd.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 정맥주사액 시장(2029년) : 새로운 기회를 제공하는 국가
• 정맥주사액 시장(2029년) : 새로운 기회를 제공하는 부문
• 정맥주사액 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Intravenous solutions are sterile liquids administered directly into a patient's bloodstream, primarily for purposes of hydration, medication delivery, or nutrient supplementation. These solutions play a crucial role in intravenous therapy, serving to restore or maintain normal fluid volume and electrolyte balance in situations where oral administration is not feasible.

The main types of products within the category of intravenous solutions include total parenteral nutrition (TPN) and peripheral parenteral nutrition. Total parenteral nutrition is a method employed to provide essential nutrients and fluids directly into the bloodstream for individuals unable to eat or absorb nutrients through the digestive system. Various nutrients, including carbohydrates, vitamins and minerals, single-dose amino acids, parenteral lipid emulsion, among others, are utilized in applications such as basic intravenous (IV) solution, nutritional intravenous (IV) solution, blood intravenous (IV) solution, drug intravenous (IV) solution, and irrigation intravenous (IV) solution. End users of these intravenous solutions include hospitals, clinics, ambulatory surgery centers, and home care settings.

The intravenous solutions market research report is one of a series of new reports from The Business Research Company that provides intravenous solutions market statistics, including intravenous solutions industry global market size, regional shares, competitors with an intravenous solutions market share, detailed intravenous solutions market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous solutions industry. This intravenous solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous solutions market size has grown strongly in recent years. It will grow from $14 billion in 2024 to $15.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to rise in surgical procedures, growing prevalence of chronic diseases, expansion of home healthcare, stringent regulations ensuring product safety, increased focus on patient hydration, global emergency preparedness initiatives.

The intravenous solutions market size is expected to see strong growth in the next few years. It will grow to $20.51 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to population growth and aging, increasing surgical interventions, rising incidence of infectious diseases, telemedicine and remote patient monitoring, focus on preventive healthcare, global health security investments, patient-centric care trends. Major trends in the forecast period include increased demand for parenteral nutrition solutions, rise in adoption of pre-mixed iv solutions, expansion of home infusion therapies, introduction of electrolyte-balanced solutions, introduction of novel drug additives and adjuncts, integration of smart iv systems for monitoring.

The rising prevalence of cancer is projected to drive the growth of the intravenous solutions market in the coming years. Cancer encompasses a range of diseases characterized by uncontrolled cell proliferation, with the capability to invade nearby tissues and metastasize to other areas of the body. Intravenous solutions are frequently utilized in cancer treatment to administer chemotherapy medications and maintain patient hydration throughout therapy. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, forecasted that by 2050, there would be over 35 million new cancer cases, marking a 77% increase from the estimated 20 million cases reported in 2022. Consequently, the increasing incidence of cancer is propelling the growth of the intravenous solutions market.

The increasing number of surgical procedures is also expected to contribute to the expansion of the intravenous solutions market. Surgical procedures, employed to treat various diseases and disorders through incisions or invasive approaches, rely on intravenous solutions for essential support, including hydration, electrolyte balance, medication administration, and emergency interventions. As an illustration, data from the International Society of Aesthetic Plastic Surgery in September 2023 revealed that in 2022, plastic surgeons worldwide conducted approximately 14.9 million surgical and 18.8 million non-surgical procedures, indicating an 11.2% increase in total procedures. Therefore, the growing number of surgical procedures is driving the growth of the intravenous solutions market.

Key companies in the intravenous solutions market are strategically focusing on the development of innovative syringes, such as pre-filled and ready-to-administer syringes, to gain a competitive advantage. Pre-filled and ready-to-administer syringes come preloaded with medication, designed for immediate use without the need for manual filling or preparation. For instance, in August 2023, GENIXUS Corp., a US-based healthcare company, introduced KinetiX Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer (RTA) syringes. These syringes are made of transparent, durable polymer material, eliminating risks associated with glass syringes. They are pre-filled and ready for administration, saving time and reducing medication errors. The product possesses features such as RFID-enabled technology with KitCheck, intuitive labeling, and a color-coded plunger rod for rapid identification.

In August 2022, CSL Limited, an Australia-based specialty biotechnology company, acquired Vifor Pharma AG for an undisclosed amount. This strategic acquisition enables CSL Limited to diversify its portfolio, expand its product offerings, increase revenue, and access new markets. Vifor Pharma AG, based in Switzerland, is a pharmaceutical manufacturing company providing intravenous (IV) solutions for the treatment of iron deficiency, nephrology, and rare diseases.

Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intravenous solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intravenous solutions market consists of sales of dextrose 5% in water (D5W), 0.45% sodium chloride (half normal saline), dextrose 5% in normal saline (D5NS), 0.2% sodium chloride (hypotonic saline), and dextrose 10% in water (D10W). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intravenous solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intravenous solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Total Parenteral Nutrition; Peripheral Parenteral Nutrition
• 2) By Nutrients: Carbohydrates; Vitamins And Minerals; Single Dose Amino Acids; Parenteral Lipid Emulsion; Other Nutrients
• 3) By Application: Basic Intravenous (IV) Solution; Nutritional Intravenous (IV) Solution; Blood Intravenous (IV) Solution; Drug Intravenous (IV) Solution; Irrigation Intravenous (IV) Solution
• 4) By End User: Hospitals; Clinics; Ambulatory Surgery Centers; Home Care Settings
• Subsegments:
• 1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions; Amino Acid Solutions; Lipid Solutions; Electrolyte Solutions; Multivitamin Solutions
• 2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions; Amino Acid Solutions; Lipid Solutions; Electrolyte Solutions
• Companies Mentioned: Pfizer Inc.; Abbott Laboratories; Eli Lilly and Company; Fresenius SE & Co. KGaA; Becton, Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intravenous Solutions Market Characteristics

3. Intravenous Solutions Market Trends And Strategies

4. Intravenous Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Intravenous Solutions Growth Analysis And Strategic Analysis Framework

• 5.1. Global Intravenous Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Intravenous Solutions Market Growth Rate Analysis
• 5.4. Global Intravenous Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Intravenous Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Intravenous Solutions Total Addressable Market (TAM)

6. Intravenous Solutions Market Segmentation

• 6.1. Global Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition
• 6.2. Global Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carbohydrates
• Vitamins And Minerals
• Single Dose Amino Acids
• Parenteral Lipid Emulsion
• Other Nutrients
• 6.3. Global Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Basic Intravenous (IV) Solution
• Nutritional Intravenous (IV) Solution
• Blood Intravenous (IV) Solution
• Drug Intravenous (IV) Solution
• Irrigation Intravenous (IV) Solution
• 6.4. Global Intravenous Solutions Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgery Centers
• Home Care Settings
• 6.5. Global Intravenous Solutions Market, Sub-Segmentation Of Total Parenteral Nutrition (TPN), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carbohydrate Solutions
• Amino Acid Solutions
• Lipid Solutions
• Electrolyte Solutions
• Multivitamin Solutions
• 6.6. Global Intravenous Solutions Market, Sub-Segmentation Of Peripheral Parenteral Nutrition (PPN), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carbohydrate Solutions
• Amino Acid Solutions
• Lipid Solutions
• Electrolyte Solutions

7. Intravenous Solutions Market Regional And Country Analysis

• 7.1. Global Intravenous Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Intravenous Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intravenous Solutions Market

• 8.1. Asia-Pacific Intravenous Solutions Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intravenous Solutions Market

• 9.1. China Intravenous Solutions Market Overview
• 9.2. China Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intravenous Solutions Market

• 10.1. India Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intravenous Solutions Market

• 11.1. Japan Intravenous Solutions Market Overview
• 11.2. Japan Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intravenous Solutions Market

• 12.1. Australia Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intravenous Solutions Market

• 13.1. Indonesia Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intravenous Solutions Market

• 14.1. South Korea Intravenous Solutions Market Overview
• 14.2. South Korea Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intravenous Solutions Market

• 15.1. Western Europe Intravenous Solutions Market Overview
• 15.2. Western Europe Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intravenous Solutions Market

• 16.1. UK Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intravenous Solutions Market

• 17.1. Germany Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intravenous Solutions Market

• 18.1. France Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intravenous Solutions Market

• 19.1. Italy Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intravenous Solutions Market

• 20.1. Spain Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intravenous Solutions Market

• 21.1. Eastern Europe Intravenous Solutions Market Overview
• 21.2. Eastern Europe Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intravenous Solutions Market

• 22.1. Russia Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intravenous Solutions Market

• 23.1. North America Intravenous Solutions Market Overview
• 23.2. North America Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intravenous Solutions Market

• 24.1. USA Intravenous Solutions Market Overview
• 24.2. USA Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intravenous Solutions Market

• 25.1. Canada Intravenous Solutions Market Overview
• 25.2. Canada Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intravenous Solutions Market

• 26.1. South America Intravenous Solutions Market Overview
• 26.2. South America Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intravenous Solutions Market

• 27.1. Brazil Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intravenous Solutions Market

• 28.1. Middle East Intravenous Solutions Market Overview
• 28.2. Middle East Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intravenous Solutions Market

• 29.1. Africa Intravenous Solutions Market Overview
• 29.2. Africa Intravenous Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Intravenous Solutions Market, Segmentation By Nutrients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Intravenous Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intravenous Solutions Market Competitive Landscape And Company Profiles

• 30.1. Intravenous Solutions Market Competitive Landscape
• 30.2. Intravenous Solutions Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Intravenous Solutions Market Other Major And Innovative Companies

• 31.1. Baxter International Inc.
• 31.2. Otsuka Pharmaceutical Co. Ltd.
• 31.3. CSL Limited
• 31.4. B. Braun Melsungen AG
• 31.5. Grifols S.A.
• 31.6. Terumo Corporation
• 31.7. Nipro Corporation
• 31.8. Sichuan Kelun Pharmaceutical Co. Ltd.
• 31.9. Cipla Limited
• 31.10. Hikma Pharmaceuticals PLC
• 31.11. ICU Medical Inc.
• 31.12. Gland Pharma Limited
• 31.13. Cisen Pharmaceutical Co. Ltd.
• 31.14. Amsino International Inc.
• 31.15. JW Life Science Co. Ltd.

32. Global Intravenous Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intravenous Solutions Market

34. Recent Developments In The Intravenous Solutions Market

35. Intravenous Solutions Market High Potential Countries, Segments and Strategies

• 35.1 Intravenous Solutions Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Intravenous Solutions Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Intravenous Solutions Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료